Banque Cantonale Vaudoise Bluebird Bio, Inc. Transaction History

Banque Cantonale Vaudoise

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	BUY	$2.94 - $5.23 $26 - $47	9 Added 1.69%	541 $2,000
Q1 2022 May 09, 2022	SELL	$4.07 - $10.6 $3,838 - $9,995	-943 Reduced 63.93%	532 $3,000
Q4 2021 Feb 14, 2022	SELL	$8.96 - $16.31 $985 - $1,794	-110 Reduced 6.94%	1,475 $15,000
Q3 2021 Oct 29, 2021	SELL	$11.24 - $21.0 $606 - $1,134	-54 Reduced 3.29%	1,585 $30,000
Q1 2021 May 11, 2021	SELL	$16.59 - $33.89 $530 - $1,084	-32 Reduced 1.92%	1,639 $49,000
Q4 2020 Feb 05, 2021	SELL	$27.5 - $37.92 $1,100 - $1,516	-40 Reduced 2.34%	1,671 $72,000
Q3 2020 Oct 30, 2020	BUY	$34.44 - $43.75 $206 - $262	6 Added 0.35%	1,711 $59,000
Q2 2020 Jul 22, 2020	SELL	$27.12 - $45.97 $1,491 - $2,528	-55 Reduced 3.13%	1,705 $104,000
Q1 2020 May 14, 2020	SELL	$26.16 - $63.5 $69,951 - $169,799	-2,674 Reduced 60.31%	1,760 $81,000
Q4 2019 Feb 10, 2020	BUY	$46.96 - $61.67 $208,220 - $273,444	4,434 New	4,434 $389,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

Stay updated on Banque Cantonale Vaudoise with notifications on news.